+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Antidepressant"

From
Psychedelic Drugs Market - Global Strategic Business Report - Product Thumbnail Image

Psychedelic Drugs Market - Global Strategic Business Report

  • Report
  • March 2026
  • 382 Pages
  • Global
From
From
From
From
From
Treatment Resistant Depression - Pipeline Insight, 2025 - Product Thumbnail Image

Treatment Resistant Depression - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Postpartum Depression - Pipeline Insight, 2025 - Product Thumbnail Image

Postpartum Depression - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Major Depressive Disorder - Pipeline Insight, 2025 - Product Thumbnail Image

Major Depressive Disorder - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 180 Pages
  • Global
From
Bipolar Disorder (Manic Depression)- Pipeline Insight, 2025 - Product Thumbnail Image

Bipolar Disorder (Manic Depression)- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
Bipolar Depression - Pipeline Insight, 2025 - Product Thumbnail Image

Bipolar Depression - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Serotonin Receptor 2 Angonist - Pipeline Insight, 2025 - Product Thumbnail Image

Serotonin Receptor 2 Angonist - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Psychedelic Drugs Market Report 2025 - Product Thumbnail Image

Psychedelic Drugs Market Report 2025

  • Report
  • September 2025
  • 250 Pages
  • Global
From
From
Schizoaffective Disorder - Pipeline Insight, 2025 - Product Thumbnail Image

Schizoaffective Disorder - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Anxiety Disorder Treatment - Global Strategic Business Report - Product Thumbnail Image

Anxiety Disorder Treatment - Global Strategic Business Report

  • Report
  • March 2026
  • 196 Pages
  • Global
From
From
Treatment Resistant Depression Drug Pipeline Analysis Report 2025 - Product Thumbnail Image

Treatment Resistant Depression Drug Pipeline Analysis Report 2025

  • Drug Pipelines
  • June 2025
  • 200 Pages
  • Global
From
Major Depressive Disorder Epidemiology Forecast 2025-2034 - Product Thumbnail Image

Major Depressive Disorder Epidemiology Forecast 2025-2034

  • Report
  • June 2025
  • 150 Pages
  • Global
From
Loading Indicator

The Antidepressant market is a subset of the Mental Disorders Drugs market, which includes medications used to treat mental health conditions such as depression, anxiety, bipolar disorder, and schizophrenia. Antidepressants are the most commonly prescribed medications for treating depression, and are typically divided into two categories: selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs). These medications work by increasing the levels of serotonin and norepinephrine in the brain, which can help to improve mood and reduce symptoms of depression. Some of the major companies in the Antidepressant market include Eli Lilly, Pfizer, GlaxoSmithKline, AstraZeneca, and Bristol-Myers Squibb. These companies produce a variety of antidepressants, including SSRIs and SNRIs, as well as other medications used to treat mental health conditions. Show Less Read more